Beximco Pharmaceuticals Ltd., of Dhaka, Bangladesh, said that it has entered into a non-binding memorandum of understanding under which in may acquire 85.22 percent of Nuvista Pharma, another Bangladeshi drugmaker specializing in hormones and steroid drugs.